These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 181662)

  • 1. [Study of the toxigenic properties of a mixture of the S- and R-forms of Clostridium perfringens 28 (BP6K)].
    Kalinichenko NF; Biriukova SV; Starobinets ZG; Podgornaia LG
    Mikrobiol Zh; 1976; 38(2):197-200. PubMed ID: 181662
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the study of the toxico-infective properties of Cl. perfringens].
    Khazanova VV
    Lab Delo; 1969; 3():164-7. PubMed ID: 4185182
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of the arginine desimidase system in toxigenic and weak-toxigenic strains of Clostridium perfringens type A].
    Blagoveshchenskiĭ VA; Dolgikh MS; Borishpolets ZI
    Dokl Akad Nauk SSSR; 1969; 188(2):458-61. PubMed ID: 4315663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Formation of toxins by Clostridium perfringens types C and D].
    Urguev KR
    Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nitrogenous components of the nutrient medium in culturing Clostridium perfringens type D].
    Zhuravel' ESh
    Veterinariia; 1968 Jun; 45(6):25-6. PubMed ID: 4310429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors participating in the formation of Cl. perfringens BP6K alpha-toxin in media of determined chemical composition. I. The mechanism of the stimulating effect of an excess of arginine on toxin formation].
    Mekhedov LN
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):117-24. PubMed ID: 4311979
    [No Abstract]   [Full Text] [Related]  

  • 8. Medium for toxin production by Clostridium perfringens in continuous culture.
    Chou G
    Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the dermotoxins of the 6 Clostridium welchii types in rabbits].
    Matthes S
    Zentralbl Bakteriol Orig; 1965 Jul; 196(4):508-15. PubMed ID: 4287430
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factors causing the restoration of toxic properties in centrifugates of Cl. perfringens cultures which lost their toxicity].
    Zanchevskaia TA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):115-20. PubMed ID: 4288945
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuraminidase in the cells and toxins of Cl. perfringens].
    Ispolatovskaia MV; Tokinova TN; Cherikovskaia EN; Borishpolets ZI
    Vopr Med Khim; 1973; 19(1):49-54. PubMed ID: 4362796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the production of anaerobic toxins. 2. Type A Clostridium perfringens toxin].
    Vitèz I; Maróczi J
    Acta Pharm Hung; 1968 Nov; 38(6):405-10. PubMed ID: 4303232
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxigenic types of Clostridium perfringens in feed].
    Ivanov VG
    Veterinariia; 1978 Apr; (4):27-9. PubMed ID: 207013
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dynamics of the formation of different components of the toxin of Cl. perfringens type A].
    Ispolatovskaia MV; Larina IA; Loseva LP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):110-4. PubMed ID: 4288944
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of molasses and whey in culture media for the development and production of a toxin from Clostridium perfringens type D].
    Silva HJ; Giulietti AM; Segovia RF; Ertola RJ
    Rev Argent Microbiol; 1982; 14(2):85-90. PubMed ID: 6101000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of glycerophosphatase of Clostridium perfringens].
    Kachelkina AI; Blagoveshchenskiĭ VA
    Dokl Akad Nauk SSSR; 1966 Dec; 171(5):1193-5. PubMed ID: 4298094
    [No Abstract]   [Full Text] [Related]  

  • 18. [On various toxigenic properties of Cl. perfringens types D and E].
    Marasanova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):147. PubMed ID: 4306878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of beta 2-toxigenic clostridium perfringens infections in animals and their predisposing factors--a review.
    Schotte U; Truyen U; Neubauer H
    J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):423-6. PubMed ID: 15606864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.